Privia Health Group (PRVA) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Privia Health Group (PRVA) has outperformed GeneDx (WGS) over the past year, losing 15.5% versus a loss of 43.3%. Over five years, PRVA leads with a -13.7% price change compared with -73.3% for WGS. Privia Health Group is the larger company by market cap ($2.61 billion vs $1.99 billion), about 1.3 times the size.
On valuation, Privia Health Group trades at a lower forward P/E (19.2x vs 55.8x for GeneDx).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRVA | WGS |
|---|---|---|
| Share price | $20.40 | $66.85 |
| Market cap | $2.61B | $1.99B |
| 1-day change | +0.47% | -2.46% |
| YTD return | -14.38% | -47.31% |
| 1-year return | -15.45% | -43.25% |
| 5-year return | -13.65% | -73.34% |
| P/E ratio (TTM) | 97.12 | — |
| Forward P/E | 19.19 | 55.77 |
| EPS (TTM) | $0.21 | $-3.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.12B | — |
| Revenue growth (YoY) | +22.26% | — |
| Net income (latest FY) | $22.92M | — |
| Operating margin | 1.61% | — |
| Net margin | 1.08% | — |
| 52-week high | $28.82 | $170.87 |
| 52-week low | $18.92 | $32.21 |
| Distance from 52-week high | -29.23% | -60.88% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +54.30% | +39.88% |
| Average volume | 1.23M | 728.47K |
| Shares outstanding | 127.73M | 29.82M |
| Employees | 1,226 | 1,300 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PRVA has outperformed WGS by 27.8 percentage points over the past year.
About Privia Health Group
PRVA stock →Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
Health Care · Medical/Nursing Services · 1,226 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
PRVA vs WGS FAQ
Which is bigger, Privia Health Group or GeneDx?
Privia Health Group (PRVA) is larger, with a market capitalization of $2.61B compared with $1.99B for GeneDx (WGS).
Which stock has performed better over the past year, PRVA or WGS?
PRVA returned -15.45% over the past 12 months, compared with -43.25% for WGS (price return, excluding dividends). Past performance does not predict future results.
Are Privia Health Group and GeneDx in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.